サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1405758

qPCR装置市場規模、シェア、動向分析レポート：検査タイプ別、地域別、セグメント予測、2023年～2030年

qPCR Instruments Market Size, Share & Trends Analysis Report By Test Type (7500, QuantStudio Dx, QuantStudio 5, ViiA 7 Dx, One Step/One Step Plus, LightCycler 2.0, Cobas 4800, CFX96, SmartCycler), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 109 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
qPCR装置市場規模、シェア、動向分析レポート：検査タイプ別、地域別、セグメント予測、2023年～2030年
出版日: 2023年12月01日
発行: Grand View Research
ページ情報: 英文 109 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

qPCR装置市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のqPCR装置市場規模は2030年までに16億4,000万米ドルに達すると予測されています。

2023年から2030年までのCAGRは7.0%で拡大する見込みです。この市場を牽引しているのは、斬新な先端製品のイントロダクションと高効率診断機器に対する需要の増加です。

qPCR装置と消耗品の需要は、世界のSARS-CoV-2感染の発生率の急増によって牽引されています。発症率の上昇は、予防的スクリーニングの件数を増やすと予想されます。これは、各国がスクリーニングを行わなければCOVID-19患者の数を確定できないという事実に起因しています。

3つの基本的な分子アッセイの小型化により、診断結果の精度と特異度が向上し、したがって分子診断製品に対する需要が増加すると予想されます。これらの改良により、POC分子診断検査が利用しやすくなり、迅速かつ効果的な検査結果が得られるようになると期待されます。例えば、Biomolecular Systems社のMic qPCRシステムの重量はわずか2キログラムで、携帯性に優れ、取り扱いが容易です。

QuantStudio 5 Dx Real-Time PCR Systemのような新発売の製品は、消費者にワークフローの改善と大量検査を提供し、より迅速な結果を提供します。費用対効果と簡素化されたソフトウェアがさらなる利点を与えています。さらに、この装置が50カ国以上で承認されていることも、市場の成長を後押しします。また、同装置にはコンパニオン診断研究用の対策も施されており、競争力を高めています。

この市場は、高度に進歩し、より正確なデジタルPCR装置の存在により、外部からの代替品の脅威が高いです。内部代替品の脅威が強いのは、市場で入手可能な製品が多数存在するためです。しかし、これらの機器の価格が高いため、全体的な脅威は減少し、中程度のレベルにとどまると予想されます。

COVID-19は診断機器の機会を増やしています。しかし、dPCRのような高度なPCR技術は、偽陽性率の低減に役立つため、新興経済諸国ではより好まれています。効率的なqPCR装置の開発研究は、機器の代替品の脅威を減らし、市場成長を改善することができます。

近年、PCRは感度、精度、効率、費用対効果の面で技術的進歩を遂げています。主要企業は競争力を維持するために新技術を導入しています。

qPCR装置市場レポートハイライト

  • GeneXpertセグメントは2022年に21.67%の最大売上シェアを占めました。これは、SARS-CoV-2パンデミック時に感染検出のために採用率が高まったことによる。
  • Rotor-Gene Q 5Plex HRM Systemは、他の多くのqPCR装置よりも早く、90分という短時間で結果を出すことができます。
  • 北米は世界のqPCR装置市場を独占し、2022年には42.73%の最大の売上シェアを占めました。この地域の成長は、規制当局の支援の高まりと新製品発売の増加によるものです。
  • アジア太平洋地域は、予測期間中最も速いCAGR 8.9%で成長すると予想されます。アンメットメディカルニーズという未開拓の機会、科学研究へのイニシアチブの増加、前向きな経済成長がこの市場の主な成長促進要因です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 qPCR装置市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • qPCR装置市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 qPCR装置：検査タイプの推定・動向分析

  • qPCR装置市場：重要なポイント
  • qPCR装置市場：動向と市場シェア分析、2022年および2030年
  • 7500
  • Quant Studio Dx
  • Quant Studio 5
  • ViiA 7 Dx
  • One Step/One Step Plus
  • LightCycler 2.0
  • Cobas 4800
  • CFX96
  • SmartCycler
  • GeneXpert
  • Rotor-Gene Q 5Plex HRM System
  • Rotor-Gene Q
  • BIOFIRE FILMARRAY System
  • BMS Mic System

第5章 qPCR装置市場：地域の推定・動向分析

  • 地域別の見通し
  • 地域別のqPCR装置市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories, Inc.
    • Danaher
    • QIAGEN
    • Agilent Technologies, Inc.
    • Abbott
    • BIOMERIEUX
    • Quantabio
    • Azure Biosystems Inc.
    • Bio Molecular Systems
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 3 North America qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 5 Canada qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 6 Europe qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 7 Europe qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 9 UK qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 10 France qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 11 Italy qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 12 Spain qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Denmark qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 14 Sweden qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 15 Norway qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 18 Japan qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 19 China qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 20 India qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 21 Australia qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 22 Thailand qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 23 South Korea qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 24 Latin America qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 25 Latin America qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 27 Mexico qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 28 Argentina qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa qpcr instruments market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 33 UAE qpcr instruments market, by test type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait qpcr instruments market, by test type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 qPCR instruments: Market outlook
  • Fig. 8 qPCR instruments: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 qPCR instruments market driver impact
  • Fig. 13 qPCR instruments market restraint impact
  • Fig. 14 qPCR instruments market strategic initiatives analysis
  • Fig. 15 qPCR instruments market: Test Type movement analysis
  • Fig. 16 qPCR instruments market: Test Type outlook and key takeaways
  • Fig. 17 7500 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 QuantStudio Dx market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 QuantStudio 5 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 ViiA 7 Dx market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 One Step/One Step Plus market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 LightCycler 2.0 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Cobas 4800 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 CFX96 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 SmartCycler market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 GeneXpert market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Rotor-Gene Q 5Plex HRM System market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Rotor-Gene Q market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 BIOFIRE FILMARRAY SYSTEMS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 BMS Mic System market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Global qPCR instruments market: Regional movement analysis
  • Fig. 32 Global qPCR instruments market: Regional outlook and key takeaways
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68038-339-3

qPCR Instruments Market Growth & Trends:

The global qPCR instruments market size is expected to reach USD 1.64 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.0% from 2023 to 2030. The market is driven by the introduction of novel advanced products and an increase in demand for highly efficient diagnostic equipment.

The demand for qPCR instruments and consumables is being driven by the spike in the incidence of SARS-CoV-2 infections globally. The rise in the incidence is expected to add to the number of preventive screenings. This can be attributed to the fact that nations cannot determine the number of COVID-19 patients without screening them.

The miniaturization of three basic molecular assays is expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to improve the availability of POC molecular diagnostic tests to yield quick and effective test results. For instance, the Mic qPCR system by Biomolecular Systems weighs only 2 kilograms, making the device highly portable and easy to handle.

Newly launched products such as QuantStudio 5 Dx Real-Time PCR System provide consumers with improved workflows and high-volume testing to provide faster results. Cost-effectiveness and software that are simplified give it additional advantages. Furthermore, the approval of the instrument in over 50 countries can help strengthen the market growth. The instrument is also equipped with measures for research companion diagnostics, giving it a competitive edge.

The market has a high threat of external substitutes owing to the presence of digital PCR instruments that are highly advanced and more accurate. The strong threat of internal substitution can be attributed to the presence of numerous products available in the market. However, the higher price of these instruments is anticipated to reduce the overall threat, keeping it at a moderate level.

COVID-19 has increased opportunities for diagnostic devices. However, advanced PCR technologies, such as dPCR, are preferred more in developed economies as they can help reduce false-positive rates. The research on developing efficient qPCR instruments can reduce the threat of substitution of devices and improve market growth.

Over recent years, PCR has witnessed technological advancements in terms of sensitivity, accuracy, efficiency, and cost-effectiveness. Key players are introducing novel technologies to maintain a competitive edge.

qPCR Instruments Market Report Highlights:

  • The GeneXpert segment accounted for the largest revenue share of 21.67% in 2022. This is attributed to its increased adoption rate during the SARS-CoV-2 pandemic to detect infections.
  • The Rotor-Gene Q 5Plex HRM System segment is expected to grow at the fastest CAGR of 8.8% during the forecast period owing to the factors such as Rotor-Gene Q 5Plex HRM System can deliver results in as little as 90 minutes, which is faster than many other qPCR instruments.
  • North America dominated the global qPCR instruments market and accounted for the largest revenue share of 42.73% in 2022. The growth of this region is attributed to the growing regulatory support and increasing launches of novel products.
  • Asia Pacific is expected to grow at the fastest CAGR of 8.9% over the forecast period. The major untapped opportunities in the form of unmet medical needs, increasing initiatives for scientific research, and positive economic growth are primary growth drivers of this market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test Type
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. qPCR Instruments Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. qPCR Instruments Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. qPCR Instruments: Test Type Estimates & Trend Analysis

  • 4.1. qPCR Instruments Market: Key Takeaways
  • 4.2. qPCR Instruments Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. 7500
    • 4.3.1. 7500 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. QuantStudio Dx
    • 4.4.1. Quant Studio Dx market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. QuantStudio 5
    • 4.5.1. Quant Studio 5 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. ViiA 7 Dx
    • 4.6.1. ViiA 7 Dx market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. One Step/One Step Plus
    • 4.7.1. One Step/One Step Plus market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. LightCycler 2.0
    • 4.8.1. Light Cycler 2.0 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Cobas 4800
    • 4.9.1. Cobas 4800 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. CFX96
    • 4.10.1. CFX96 market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. SmartCycler
    • 4.11.1. Smart Cycler market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.12. GeneXpert
    • 4.12.1. GeneXpert market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.13. Rotor-Gene Q 5Plex HRM System
    • 4.13.1. Rotor-Gene Q 5Plex HRM System market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.14. Rotor-Gene Q
    • 4.14.1. Rotor-Gene Q market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.15. BIOFIRE FILMARRAY System
    • 4.15.1. BIOFIRE FILMARRAY Systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.16. BMS Mic System
    • 4.16.1. BMS Mic System market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. qPCR Instruments Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. qPCR Instruments Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Regulatory Framework/Reimbursement Structure
      • 5.3.2.3. Competitive Scenario
      • 5.3.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Regulatory Framework/Reimbursement Structure
      • 5.3.3.3. Competitive Scenario
      • 5.3.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Denmark
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Thermo Fisher Scientific, Inc.
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. F. Hoffmann-La Roche Ltd.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Bio-Rad Laboratories, Inc.
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Danaher
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. QIAGEN
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Agilent Technologies, Inc.
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Abbott
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. BIOMERIEUX
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Quantabio
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Azure Biosystems Inc.
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. Bio Molecular Systems
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives